2(3H)-Benzoxazolone → HCID 10162370, 화합물
반응식
ClC1N=C(C)N([CH2:8][C:9]2[S:24][C:12]3[N:13]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:14](=[O:19])[N:15]([CH3:18])[C:16](=[O:17])[C:11]=3[C:10]=2[C:25]([N:27]([O:29][CH3:30])[CH3:28])=[O:26])C=1Cl.[O:32]1[C:36]2[CH:37]=[CH:38][CH:39]=[CH:40][C:35]=2[NH:34][C:33]1=[O:41]>>[CH3:30][O:29][N:27]([CH3:28])[C:25]([C:10]1[C:11]2[C:16](=[O:17])[N:15]([CH3:18])[C:14](=[O:19])[N:13]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:12]=2[S:24][C:9]=1[CH2:8][N:34]1[C:35]2[CH:40]=[CH:39][CH:38]=[CH:37][C:36]=2[O:32][C:33]1=[O:41])=[O:26]참가 물질
3
실험 절차
The subtitle compound was synthesised by the method of example 1 c) using the product of example 1 part b) and benzoxazolone. The product was isolated by SiO2 chromatography eluting with ethyl acetate/i-hexane (3:2), followed by recrystallisation with diethyl ether to so give the sub-title compound.
후처리
- customThe subtitle compound was synthesised by the method of example 1 c)
- customThe product was isolated by SiO2 chromatography
- washeluting with ethyl acetate/i-hexane (3:2)
- customfollowed by recrystallisation with diethyl ether